Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors

被引：37
|
作者：
Zettl, Heiko [1 ]
Schubert-Zsilavecz, Manfred [1 ]
Steinhilber, Dieter [1 ]
机构：
[1] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany
来源：
CHEMMEDCHEM | 2010年 / 5卷 / 02期
关键词：
DPP-4; inhibitors; drug discovery; incretin mimetics; medicinal chemistry; DIPEPTIDYL-PEPTIDASE-IV; GLUCAGON-LIKE PEPTIDE-1; TYPE-2; DIABETES-MELLITUS; ANTIHYPERGLYCEMIC PROPERTIES; HEALTHY-VOLUNTEERS; RECEPTOR AGONISTS; CRYSTAL-STRUCTURE; POTENT; PHARMACOKINETICS; PHARMACODYNAMICS;
D O I：
10.1002/cmdc.200900448
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：179 / 185
页数：7
相关论文
共 50 条
  • [31] Review on Chemistry, Analysis and Pharmacology of Teneligliptin: A Novel DPP-4 Inhibitor
    Sharma, Sanjay
    Sharma, Raksha
    Hatware, Ketan
    Patil, Kiran
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (12) : 1091 - 1100
  • [32] STRUCTURAL BIOLOGY AND MOLECULAR MODELING IN THE DESIGN OF NOVEL DPP-4 INHIBITORS
    Scapin, Giovanna
    FROM MOLECULES TO MEDICINES: STRUCTURE OF BIOLOGICAL MACROMOLECULES AND ITS RELEVANCE IN COMBATING NEW DISEASES AND BIOTERRORISM, 2009, : 153 - 168
  • [33] Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria
    Haluzik, Martin
    Frolik, Jan
    Rychlik, Ivan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [34] Alogliptin: a new addition to the class of DPP-4 inhibitors
    Andukuri, Radha
    Drincic, Andjela
    Rendell, Marc
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 117 - 126
  • [35] DPP-4 inhibitors: What may be the clinical differentiators?
    Gerich, John
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (02) : 131 - 140
  • [36] DPP-4 inhibitors: a new class of oral antidiabetics
    Gallwitz, B.
    DIABETES STOFFWECHSEL UND HERZ, 2007, 16 (01): : 43 - 50
  • [37] Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors
    Singh, Awadhesh Kumar
    Singh, Ritu
    WORLD JOURNAL OF DIABETES, 2022, 13 (06) : 466 - 470
  • [38] Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials
    Coppolino, Giuseppe
    Leporini, Christian
    Rivoli, Laura
    Ursini, Francesco
    di Paola, Eugenio Donato
    Cernaro, Valeria
    Arturi, Franco
    Bolignano, Davide
    Russo, Emilio
    De Sarro, Giovambattista
    Andreucci, Michele
    PHARMACOLOGICAL RESEARCH, 2018, 129 : 274 - 294
  • [39] Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
    Subrahmanyan, Nikhila A.
    Koshy, Rithika M.
    Jacob, Koshy
    Pappachan, Joseph M.
    CURRENT DRUG SAFETY, 2021, 16 (02) : 154 - 164
  • [40] An update on DPP-4 inhibitors in the management of type 2 diabetes
    Cahn, Avivit
    Cernea, Simona
    Raz, Itamar
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (04) : 409 - 419
12345